Trials / Completed
CompletedNCT02580331
1% Metformin Gel in the Treatment of Class II Furcation Defects
1% Metformin Gel as Local Drug Delivery in the Treatment of Class II Furcation Defects: A Randomized Controlled Clinical Trial
- Status
- Completed
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 64 (actual)
- Sponsor
- Government Dental College and Research Institute, Bangalore · Academic / Other
- Sex
- All
- Age
- 30 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
Metformin (MF), a biguanide group of anti-diabetic drug has been shown to enhance osteoblasts differentiation and inhibit osteoclast differentiation in vitro, thus may exhibit a favourable effect on alveolar bone. The present study aims to explore the efficacy of 1% MF gel as a local drug delivery system in adjunct to scaling and root planing (SRP) for the treatment of Class II furcation defects in comparison with placebo gel.
Detailed description
Background: Metformin (MF), a biguanide group of anti-diabetic drug has been shown to enhance osteoblasts differentiation and inhibit osteoclast differentiation in vitro, thus may exhibit a favourable effect on alveolar bone. The present study aims to explore the efficacy of 1% MF gel as a local drug delivery system in adjunct to scaling and root planing (SRP) for the treatment of Class II furcation defects in comparison with placebo gel. Methods: Sixty four patients with single mandibular buccal class II furcation defects were categorized into two treatment groups: SRP plus 1% MF (group 1) and SRP plus placebo (group 2). Clinical parameters were recorded at baseline, 3 months, 6 months, and 9 months, and radiographic parameters were recorded at baseline, 6 months, and 9 months. Defect fill at baseline, 6 months, and 9 months was calculated on standardized radiographs using image analysis software.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SRP and placebo | Placement of placebo gel into classII furcation defects after scaling and root planing |
| DRUG | SRP and 1% metformin | Placement of 1% metformin gel into classII furcation defects after scaling and root planing |
Timeline
- Start date
- 2014-11-01
- Primary completion
- 2015-09-01
- Completion
- 2015-09-01
- First posted
- 2015-10-20
- Last updated
- 2015-10-20
Locations
1 site across 1 country: India
Source: ClinicalTrials.gov record NCT02580331. Inclusion in this directory is not an endorsement.